As genome editing therapies move through clinical trials to regulatory approval, scientists continue the quest for the holy ...
More than a decade after Alice Corp. v. CLS Bank Int’l, the two-step framework for patent eligibility under 35 U.S.C. § 101 remains as contentious ...